Abstract: A memory unit is controlled by a first word line and a second word line. The memory unit includes a memory cell and a multi-bit input local computing cell. The memory cell stores a weight. The memory cell is controlled by the first word line and includes a local bit line transmitting the weight. The multi-bit input local computing cell is connected to the memory cell and receives the weight via the local bit line. The multi-bit input local computing cell includes a plurality of input lines and a plurality of output lines. Each of the input lines transmits a multi-bit input value, and the multi-bit input local computing cell is controlled by the second word line to generate a multi-bit output value on each of the output lines according to the multi-bit input value multiplied by the weight.

Abstract: A memory unit is controlled by a first word line and a second word line. The memory unit includes a memory cell and a multi-bit input local computing cell. The memory cell stores a weight. The memory cell is controlled by the first word line and includes a local bit line transmitting the weight. The multi-bit input local computing cell is connected to the memory cell and receives the weight via the local bit line. The multi-bit input local computing cell includes a plurality of input lines and a plurality of output lines. Each of the input lines transmits a multi-bit input value, and the multi-bit input local computing cell is controlled by the second word line to generate a multi-bit output value on each of the output lines according to the multi-bit input value multiplied by the weight.

Abstract: Disclosed herein are novel 4-anilinofuro[2,3-b]quinoline derivatives of formula (I): or a pharmaceutically acceptable salt thereof, wherein each of the substituents is given the definition as set forth in the Specification and Claims. Also disclosed are the preparation processes of these derivatives and their uses in the manufacture of pharmaceutical compositions and in the treatment of cancers.

Abstract: Disclosed herein are novel 4-anilinofuro[2,3-b]quinoline derivatives of formula (I): or a pharmaceutically acceptable salt thereof, wherein each of the substituents is given the definition as set forth in the Specification and Claims. Also disclosed are the preparation processes of these derivatives and their uses in the manufacture of pharmaceutical compositions and in the treatment of cancers.

Abstract: Disclosed herein are novel imino-indeno[1,2-c]quinoline derivatives of formula (I): or a pharmaceutically acceptable salt or solvate thereof, wherein each of the substituents is given the definition as set forth in the Specification and Claims. Also disclosed are the preparation processes of these derivatives, their synthetic precursors and their uses in the manufacture of pharmaceutical compositions for use in the treatment of cancers.

Abstract: Disclosed herein are novel imino-indeno[1,2-c]quinoline derivatives of formula (I): or a pharmaceutically acceptable salt or solvate thereof, wherein each of the substituents is given the definition as set forth in the Specification and Claims. Also disclosed are the preparation processes of these derivatives, their synthetic precursors and their uses in the manufacture of pharmaceutical compositions for use in the treatment of cancers.